Literature DB >> 21269813

[Neonatal seizures, buprenorphine abstinence syndrome, and substitutive treatment with morphine].

S Dahan1, E Elefant, I Girard, B Azcona, V Champion, D Mitanchez.   

Abstract

We report the case of a hypotrophic twin who presented neonatal abstinence syndrome to buprenorphine and developed neonatal seizures when the substitutive treatment by morphine was stopped. The other eutrophic twin did not develop withdrawal symptoms. This case demonstrates the unpredictable nature of transplacental transfer of buprenorphine. It also shows that neonatal abstinence syndrome can be potentially severe and that morphine treatment is not without risk.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21269813     DOI: 10.1016/j.arcped.2010.12.003

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  2 in total

Review 1.  Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.

Authors:  Irma Convertino; Alice Capogrosso Sansone; Alessandra Marino; Maria T Galiulo; Stefania Mantarro; Luca Antonioli; Matteo Fornai; Corrado Blandizzi; Marco Tuccori
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

2.  Poverty and Excess Length of Hospital Stay in Neonatal Opioid Withdrawal Syndrome.

Authors:  Zachary A Vesoulis; Christopher E Lust; Barbara A Cohlan; Steve M Liao; Amit M Mathur
Journal:  J Addict Med       Date:  2020 Mar/Apr       Impact factor: 4.647

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.